Skip to main content

Animations

MJFF Publications

2081 - 2090 of 6458 Results
Title
Year
  • Year
  • 2018
  • 2017
  • 2026
  • 2025
  • 2025
  • 2017
  • 2024
  • 2024
  • 2017
  • 2018
  • Summary Details
    OPEN
    Title: Validation of a performance‐based assessment of cognitive functional ability in Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27487
    Citation Count: 21
  • Summary Details
    OPEN
    Title: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-017-0456-2
    Citation Count: 100
  • Summary Details
    OPEN
    Title: Accelerating Medicines Partnership® Parkinson's Disease Proteomics: A Comprehensive Resource for Advancing Parkinson's Disease Research
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.70183
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Cognitive Performance in Early Neuronal Synuclein Disease with Hyposmia but without Motor Disability: Association with Dopamine Deficiency and Isolated Rapid Eye Movement Sleep Behavior Disorder
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/ana.27263
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Resistant starch improves Parkinson’s disease symptoms through restructuring of the gut microbiome and modulating inflammation
    Journal Name: Brain, Behavior, and Immunity
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bbi.2025.106217
    Citation Count: 2
  • Summary Details
    OPEN
    Title: S-Nitrosylation of PINK1 Attenuates PINK1/Parkin-Dependent Mitophagy in hiPSC-Based Parkinson’s Disease Models
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2017.10.068
    Citation Count: 128
  • Summary Details
    OPEN
    Title: Genetic analysis and natural history of Parkinson’s disease due to the LRRK2 G2019S variant
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awae073
    Citation Count: 49
  • Summary Details
    OPEN
    Title: A person-centered approach to characterizing longitudinal ambulatory impairment in Parkinson's disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-024-62179-9
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Dorsal Raphe Dopamine Neurons Modulate Arousal and Promote Wakefulness by Salient Stimuli
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuron.2017.05.020
    Citation Count: 283
  • Summary Details
    OPEN
    Title: L-DOPA functionalized, multi-branched gold nanoparticles as brain-targeted nano-vehicles
    Journal Name: Nanomedicine: Nanotechnology, Biology and Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nano.2018.08.011
    Citation Count: 100
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.